Tulinercept (OPRX-106) is an orally available recombinant fusion protein targeting TNF for studies related to ulcerative colitis (UC). Tulinercept is a TNF-alpha inhibitor.
CAS Number:
[1623177-41-2]
Target:
TNF Receptor
* VAT and and shipping costs not included. Errors and price changes excepted